Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency.
T S Flippo, W D Holder
https://pubmed.ncbi.nlm.nih.gov/8250714/Actively Recruiting
Led by Nottingham University Hospitals NHS Trust · Updated on 2025-07-25
100
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are studying neurological recovery in patients who have experienced nerve damage caused by nitrous oxide NOS abuse. Nitrous oxide is a commonly used recreational drug, especially among young people aged 16 to 24 in the UK. It can inactivate vitamin B12, which is essential for nerve health, leading to symptoms like tingling, weakness, and coordination problems. This study aims to better understand the severity and recovery from these nerve problems by following patients over 12 months in a prospective way, overcoming earlier studies limitations related to short follow-up and small participant numbers. Participants will be recruited from hospitals, including neurology units and emergency departments, where they have been diagnosed with NOS-induced neurological damage by a neurologist. The study does not involve any treatment interventions but follows patients remotely through five scheduled assessments over 12 months. Data collected include neurological tests like finger tapping and cognitive function tasks, health questionnaires, and step counts. Initial hospital data such as MRI scans and blood tests will also be reviewed when available. The study uses a special platform to send participants links via text message for completing assessments remotely. Participants will be involved in five remote visits at baseline, 1 month, 3 months, 6 months, and 12 months, completing various questionnaires and tasks to monitor neurological recovery. The research team will track completed visits and send reminders as needed. A nested qualitative sub-study will interview some participants about their experiences with NOS, mental health, and treatment access. The main outcome measured is improvement in the finger tapping task over 12 months, along with cognitive function, physical activity, and neuropathy-related scales.
CONDITIONS
Neurological Recovery Following NOS-SACD
N
Nikos Evangelou, FRCP, DPhil
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nottingham University Hospitals NHS Trust
Lead Sponsor
Barts & The London NHS Trust
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person or via telephone)
Duration - At enrollment
Participants have their neurological assessment, MRI, blood tests, and concomitant medications reviewed, either in hospital or remotely. Initial questionnaires and cognitive tasks are completed.
1 baseline visit (in-person or remote)
Duration - 12 months
Participants complete remote follow-up assessments including cognitive tasks, health questionnaires, and activity monitoring over 12 months.
4 remote visits at 1 month, 3 months, 6 months, and 12 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
T S Flippo, W D Holder
https://pubmed.ncbi.nlm.nih.gov/8250714/Grace Swart, Christopher Blair, Zhong Lu...
https://pubmed.ncbi.nlm.nih.gov/34427020/Jonathan Peirce, Jeremy R Gray, Sol Simpson...
https://pubmed.ncbi.nlm.nih.gov/30734206/Dongming Zheng, Fang Ba, Guorong Bi...
https://pubmed.ncbi.nlm.nih.gov/31655888/A C Kroes, J Lindemans, J Abels
https://pubmed.ncbi.nlm.nih.gov/4088327/Adam Seed, Meesha Jogia
https://pubmed.ncbi.nlm.nih.gov/32414730/Edouard Berling, Guillaume Fargeot, Karine Aure...
https://pubmed.ncbi.nlm.nih.gov/34741241/Amir Garakani, Robert J Jaffe, Dipal Savla...
https://pubmed.ncbi.nlm.nih.gov/27037733/Yetunde B Omotosho, Grace W Ying, Richard Orji...
https://pubmed.ncbi.nlm.nih.gov/35475085/Adam R Winstock, Jason A Ferris
https://pubmed.ncbi.nlm.nih.gov/31679459/Nottingham University Hospitals NHS Trust
Lead Sponsor
Barts & The London NHS Trust
Collaborating Sponsor